The captioned paper (attached) explores patent validity challenges at the PTO are now under fire in the Restasis case, Allergan, Inc. v. Teva Pharmaceuticals USA, Inc.(on its way to the Federal Circuit), as well as two cases that will enjoy merits arguments at the Supreme Court in the next month, Oil States Energy Services v. Greene’s Energy Group; and  SAS Institute v. Matal.